| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |